Get the Stockscreener App
144.12
3.42%
4.5933
Repligen Corp stock is traded at $144.12, with a volume of 176.87K.
It is up +3.42% in the last 24 hours and up +5.55% over the past month.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
See More
Previous Close:
$139.53
Open:
$138.32
24h Volume:
176.87K
Relative Volume:
0.27
Market Cap:
$8.03B
Revenue:
$607.45M
Net Income/Loss:
$14.84M
P/E Ratio:
71.00
EPS:
2.03
Net Cash Flow:
$109.54M
1W Performance:
+6.99%
1M Performance:
+5.55%
6M Performance:
-13.62%
1Y Performance:
-4.03%
1-Day Range:
$138.32
$144.82
1-Week Range:
$133.56
$144.82
52-Week Range:
$113.50
$211.13
Repligen Corp Stock (RGEN) Company Profile
Name
Repligen Corp
Sector
Industry
Phone
(781) 449-9560
Address
41 SEYON STREET, WALTHAM, MA
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-18-24 | Initiated | Guggenheim | Neutral |
| Dec-04-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Mar-28-23 | Initiated | The Benchmark Company | Buy |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-20-22 | Initiated | UBS | Buy |
| Oct-14-21 | Initiated | Exane BNP Paribas | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| May-07-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-23-20 | Reiterated | H.C. Wainwright | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Nov-01-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Oct-15-19 | Initiated | SVB Leerink | Outperform |
| Aug-28-19 | Reiterated | First Analysis Sec | Outperform |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jul-22-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Dec-17-18 | Upgrade | CL King | Neutral → Buy |
| Nov-12-18 | Downgrade | CL King | Buy → Neutral |
| Sep-26-18 | Initiated | H.C. Wainwright | Neutral |
| Dec-08-17 | Initiated | Citigroup | Buy |
| Dec-05-17 | Initiated | JP Morgan | Overweight |
| Nov-13-17 | Initiated | CL King | Buy |
| Oct-02-17 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
| Jul-21-17 | Initiated | William Blair | Outperform |
| Feb-13-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
View All
Repligen Corp Stock (RGEN) Latest News
Repligen Corporation to Present at Upcoming Investor Conferences - StockTitan
Repligen Co. (NASDAQ:RGEN) Position Boosted by Blue Trust Inc. - Defense World
New York State Common Retirement Fund Acquires 71,274 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Conestoga Capital Advisors LLC Sells 6,167 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen to Report Third Quarter 2024 Financial Results - StockTitan
Repligen Co. (NASDAQ:RGEN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Repligen Co. (NASDAQ:RGEN) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Raymond James & Associates Increases Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Allspring Global Investments Holdings LLC Has $37.81 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen (NASDAQ:RGEN) Shares Gap DownHere's Why - MarketBeat
Repligen (RGEN) Earnings Expected to Grow: What to Know Ahead of Q3 Release - Yahoo Finance
Repligen (NASDAQ:RGEN) Shares Gap UpHere's Why - MarketBeat
Repligen Corp (RGEN) Trading 3.16% Higher on Oct 17 - GuruFocus.com
Repligen Corp. (RGEN) gets rating Initiated from Wells Fargo - Knox Daily
Global Hollow Fiber Filtration Market Overall Study Report - openPR
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More - Yahoo Finance
Diversified Trust Co Purchases 7,520 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Financial Analysis: Repligen Corp. (RGEN)’s Ratios Unveil Key Insights - The Dwinnex
Taking the lead: Repligen Corp. (RGEN) - SETE News
Examining the Potential Price Growth of Repligen Corp. (RGEN) - Knox Daily
Dana Investment Advisors Inc. Has $765,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Cubist Systematic Strategies LLC Has $781,000 Stake in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of Montreal Can Has $4.64 Million Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
3,900 Shares in Repligen Co. (NASDAQ:RGEN) Purchased by MBB Public Markets I LLC - MarketBeat
Repligen (FRA:RGN) Cyclically Adjusted PS Ratio : 18.47 (As of Oct. 02, 2024) - GuruFocus.com
Repligen Offers Differentiated Solutions as a Leading Bioprocessing Supplier - Morningstar
Ariadne Wealth Management LP Invests $499,000 in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Healthy Upside Potential: Repligen Corp. (RGEN) - SETE News
Investing in Repligen Corp. (RGEN) Is Getting More Attractive - Knox Daily
Repligen's SWOT analysis: bioprocessing leader's stock faces growth hurdles - Investing.com
APG Asset Management N.V. Has $3.22 Million Position in Repligen Co. (NASDAQ:RGEN) - MarketBeat
Xponance Inc. Sells 2,123 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Dimensional Fund Advisors LP Acquires 121,305 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Investing in Repligen Corp. (RGEN) might be a great opportunity, but the stock is a bit overvalued - US Post News
Repligen Co. (NASDAQ:RGEN) Shares Sold by Blair William & Co. IL - MarketBeat
Market Update: Repligen Corp. (RGEN) Sees Negative Movement, Closing at 139.60 - The Dwinnex
Repligen (NASDAQ:RGEN) Earns Outperform Rating from Royal Bank of Canada - MarketBeat
Evaluating Repligen: Insights From 6 Financial Analysts - Benzinga
Repligen Co. (NASDAQ:RGEN) Shares Acquired by Marshall Wace LLP - MarketBeat
Repligen Corp (RGEN) Trading Down 2.9% on Sep 25 - GuruFocus.com
Repligen Corp. (RGEN) Becoming More Attractive for Investors - Knox Daily
Repligen Co. (NASDAQ:RGEN) Shares Sold by Fred Alger Management LLC - MarketBeat
Repligen Opens Training & Innovation Center to Elevate Customer Experience - StockTitan
Amalgamated Bank Has $3.36 Million Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Sold by Ensign Peak Advisors Inc - MarketBeat
Repligen Co. (NASDAQ:RGEN) Holdings Raised by Mutual of America Capital Management LLC - Defense World
Repligen Co. (NASDAQ:RGEN) Shares Purchased by Thrivent Financial for Lutherans - MarketBeat
Granite Investment Partners LLC Lowers Stake in Repligen Co. (NASDAQ:RGEN) - Defense World
Public Employees Retirement Association of Colorado Purchases 4,627 Shares of Repligen Co. (NASDAQ:RGEN) - MarketBeat
Repligen Co. (NASDAQ:RGEN) Shares Sold by Bradley Foster & Sargent Inc. CT - Defense World
Repligen Corp Stock (RGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Repligen Corp Stock (RGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hunt Anthony | Director |
Sep 10 '24 |
Sale |
145.37 |
22,191 |
3,225,927 |
139,840 |
0.71%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):